The dysfunction of TGF-β1 signaling has been associated with neurodegenerative disorders; an impairment of TGF-β1 signaling has been reported in AD pathogenesis, thereby contributing to Aβ accumulation, activation of microglia as well as to the progression of neurodegeneration [42,45]. Here, TGFB1 is linked to Alzheimer disease.